SMDBid | siRNA (sense/antisense) 5'>3' | Modification (sense/antisense) | Position (sense/antisense) |
Modified component (sense/antisense) |
Efficacy (%) | Reference |
SM4546 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid* 2-Deoxythymidine Triazole-linked nucleic acid |
1 * 20,21 20 |
Sugar; Backbone Backbone |
51 percent target mRNA inhibition | 22260772 |
SM4551 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid* 2-Deoxythymidine Triazole-linked nucleic acid |
14 * 20,21 20 |
Sugar; Backbone Backbone |
38 percent target mRNA inhibition | 22260772 |
SM4554 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid Triazole-linked nucleic acid |
20 20 |
Backbone Backbone |
76 percent target mRNA inhibition | 22260772 |
SM4556 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid Triazole-linked nucleic acid |
15,20 20 |
Backbone Backbone |
43 percent target mRNA inhibition | 22260772 |
SM4558 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
2-Deoxythymidine Triazole-linked nucleic acid |
20,21 20 |
Sugar Backbone |
45 percent target mRNA inhibition | 22260772 |
SM4561 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid* 2-Deoxythymidine Triazole-linked nucleic acid |
1 * 20,21 20 |
Sugar; Backbone Backbone |
58 percent target mRNA inhibition | 22260772 |
SM4566 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid* 2-Deoxythymidine Triazole-linked nucleic acid |
14 * 20,21 20 |
Sugar; Backbone Backbone |
93 percent target mRNA inhibition | 22260772 |
SM4569 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid Triazole-linked nucleic acid |
20 20 |
Backbone Backbone |
96 percent target mRNA inhibition | 22260772 |
SM4571 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid Triazole-linked nucleic acid |
15,20 20 |
Backbone Backbone |
81 percent target mRNA inhibition | 22260772 |
SM4573 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
2-Deoxythymidine Triazole-linked nucleic acid |
20,21 20 |
Sugar Backbone |
89 percent target mRNA inhibition | 22260772 |
SM4576 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid* 2-Deoxythymidine Triazole-linked nucleic acid |
1 * 20,21 20 |
Sugar; Backbone Backbone |
96 percent target mRNA inhibition | 22260772 |
SM4581 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid* 2-Deoxythymidine Triazole-linked nucleic acid |
14 * 20,21 20 |
Sugar; Backbone Backbone |
97 percent target mRNA inhibition | 22260772 |
SM4584 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid Triazole-linked nucleic acid |
20 20 |
Backbone Backbone |
96 percent target mRNA inhibition | 22260772 |
SM4586 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
Triazole-linked nucleic acid Triazole-linked nucleic acid |
15,20 20 |
Backbone Backbone |
85 percent target mRNA inhibition | 22260772 |
SM4588 |
CUUACGCUGAGUACUUCGATT UCGAAGUACUCAGCGUAAGTT |
2-Deoxythymidine Triazole-linked nucleic acid |
20,21 20 |
Sugar Backbone |
98 percent target mRNA inhibition | 22260772 |